Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-31 @ 5:51 PM
Study NCT ID:
NCT01011933
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2009-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-10
First Submit QC Date:
None
Study First Post Date:
2009-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-21
Results First Submit QC Date:
None
Results First Post Date:
2014-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-19
Last Update Post Date:
2019-07-23
Last Update Post Date Type:
ACTUAL